OnCore Login

Return to Trial Database

LUN04-78

Pemetrexed (Alimta) in Patients with Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer

Status

Study Completed

Cancer Type(s)

Lung

Study Contact

Publications

Pemetrexed plus cetuximab in patients (pts) with recurrent non-small cell lung cancer (NSCLC): a phase I-IIa dose-ranging study
  • S Jalal, D Waterhouse, M Edelman, S Nattam, R Ansari, K Koneru, M Yu, J Shen, T Breen, N Hanna
Pemetrexed in Patients (pts) with Relapsed Small Cell Lung Cancer (SCLC): A Phase II Study
  • N Hanna, R Ansari, S Bhatia, R Govindan, D Bruetman, M Guarino, W Fisher, A White, T Breen, B Juliar
Pemetrexed in Second Line and beyond Small Cell Lung Cancer: A Phase II Study
  • S Jalal, R Ansari, R Govindan,S Bhatia, D Bruetman, W Fisher, G Masters, A White, D Stover, M Yu, N Hanna

Trial Locations

All sites in which the trial LUN04-78 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278